CVRx, Inc. Files 8-K for Regulation FD Disclosure

TL;DR

CVRX filed an 8-K for a Reg FD disclosure. Details TBD.

AI Summary

On June 5, 2024, CVRx, Inc. filed an 8-K to disclose a Regulation FD event. The filing does not contain specific details about the nature of the event, dollar amounts, or other parties involved, but it indicates a material event requiring public disclosure.

Why It Matters

This filing signals a potentially material event that the company is required to disclose to the public under Regulation FD, impacting investor awareness.

Risk Assessment

Risk Level: medium — The filing itself is a standard disclosure, but the lack of specific details about the Regulation FD event creates uncertainty and potential risk for investors.

Key Players & Entities

• CVRx, Inc. (company) — Registrant
• June 5, 2024 (date) — Date of earliest event reported
• Regulation FD (regulation) — Type of disclosure

FAQ

Key Financial Figures

• $0.01 — ich registered Common stock, par value $0.01 per share CVRX The Nasdaq Global S
• $50.0 million — inues to expect: Total revenue between $50.0 million and $53.0 million; Gross margin betwe
• $53.0 million — Total revenue between $50.0 million and $53.0 million; Gross margin between 83.0% and 85.0%
• $92.0 million — 85.0%; and Operating expenses between $92.0 million and $98.0 million. For the second qua
• $98.0 million — ting expenses between $92.0 million and $98.0 million. For the second quarter of 2024, the
• $11.3 million — expect to report total revenue between $11.3 million and $12.3 million. The information con
• $12.3 million — total revenue between $11.3 million and $12.3 million. The information contained in this Ite

Filing Documents

• tm2416471d1_8k.htm (8-K) — 31KB
• 0001104659-24-068492.txt ( ) — 204KB
• cvrx-20240605.xsd (EX-101.SCH) — 3KB
• cvrx-20240605_lab.xml (EX-101.LAB) — 33KB
• cvrx-20240605_pre.xml (EX-101.PRE) — 22KB
• tm2416471d1_8k_htm.xml (XML) — 4KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. As previously announced, the management team of CVRx, Inc. (the "Company") will present at the William Blair 44 th Annual Growth Stock Conference today, June 5, 2024, at 8:40 a.m. Central Time. A live webcast of the conference presentation will be available online at the investor relations page of the Company's website at ir.cvrx.com. At the conference, the Company intends to reaffirm full year 2024 guidance previously provided in the Company's first quarter 2024 earnings release, as follows, and will also discuss second quarter 2024 developments. Business Outlook (reaffirmed as of June 5, 2024) For the full year of 2024, the Company continues to expect: Total revenue between $50.0 million and $53.0 million; Gross margin between 83.0% and 85.0%; and Operating expenses between $92.0 million and $98.0 million. For the second quarter of 2024, the Company continues to expect to report total revenue between $11.3 million and $12.3 million. The information contained in this Item 7.01 is being furnished and shall not be deemed to be "filed" with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such a filing.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including statements regarding our future financial performance (including our financial guidance regarding full year and second quarter 2024 results), our anticipated growth strategies, anticipated trends in our industry, our business prospects and our opportunities. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "outlook," "guidance," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. The forward-looking statements in this Current Report on Form 8-K are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. These forward-looking statements speak only as of the date of this Current Report on Form 8-K and are subject to a number of known and unknown risks, uncertainties and assumptions, including, but not limited to, our history of significant losses, which we expect to continue; our limited history operating as a commercial company and our dependence on a single product, Barostim; our limited commercial sales experience marketing and selling Barostim; our ability to demonstrate to physicians and patients the merits of our Barostim; any failure by third-party payors to provide adequate coverage and reimbursement for the use of Barostim; our competitors' success in developing and marketing products that are safer, more effective, less costly, easier to use or otherwise more attractiv

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVRx, Inc. Date: June 5, 2024 By: /s/ Jared Oasheim Name: Jared Oasheim Its: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR